BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8077853)

  • 1. Altered apolipoprotein B metabolism in very low density lipoprotein from lovastatin-treated guinea pigs.
    Berglund LF; Beltz WF; Elam RL; Witztum JL
    J Lipid Res; 1994 Jun; 35(6):956-65. PubMed ID: 8077853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
    Aguilar-Salinas CA; Barrett PH; Kelber J; Delmez J; Schonfeld G
    J Lipid Res; 1995 Jan; 36(1):188-99. PubMed ID: 7706943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
    Arad Y; Ramakrishnan R; Ginsberg HN
    J Lipid Res; 1990 Apr; 31(4):567-82. PubMed ID: 2351867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach.
    Berglund L; Witztum JL; Galeano NF; Khouw AS; Ginsberg HN; Ramakrishnan R
    J Lipid Res; 1998 Apr; 39(4):913-24. PubMed ID: 9555954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes.
    Parhofer KG; Hugh P; Barrett R; Bier DM; Schonfeld G
    J Lipid Res; 1991 Aug; 32(8):1311-23. PubMed ID: 1770313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions.
    Huff MW; Telford DE
    Metabolism; 1989 Mar; 38(3):256-64. PubMed ID: 2918845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males.
    Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs.
    Huff MW; Telford DE; Barrett PH
    Arterioscler Thromb; 1992 Aug; 12(8):902-10. PubMed ID: 1637788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
    Packard CJ; Demant T; Stewart JP; Bedford D; Caslake MJ; Schwertfeger G; Bedynek A; Shepherd J; Seidel D
    J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the metabolism of apolipoprotein B in hypertriglyceridemic subjects using simultaneous administration of tritiated leucine and radioiodinated very low density lipoprotein.
    Beltz WF; Kesäniemi YA; Miller NH; Fisher WR; Grundy SM; Zech LA
    J Lipid Res; 1990 Mar; 31(3):361-74. PubMed ID: 2341804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of very low density lipoprotein apo B metabolism by dietary fat saturation and chain length in the guinea pig.
    Abdel-Fattah G; Fernandez ML; McNamara DJ
    Lipids; 1998 Jan; 33(1):23-31. PubMed ID: 9470170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mevinolin and cholestyramine inhibit the direct synthesis of low density lipoprotein apolipoprotein B in miniature pigs.
    Huff MW; Telford DE; Woodcroft K; Strong WL
    J Lipid Res; 1985 Oct; 26(10):1175-86. PubMed ID: 3906004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets.
    Himber J; Missano B; Rudling M; Hennes U; Kempen HJ
    J Lipid Res; 1995 Jul; 36(7):1567-85. PubMed ID: 7595080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
    Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
    Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins.
    Arad Y; Ramakrishnan R; Ginsberg HN
    Metabolism; 1992 May; 41(5):487-93. PubMed ID: 1588827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.